Kiernan Jane E 4
4 · Axonics, Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Kiernan Jane E
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$34.10/sh+4,167$142,095→ 21,761 total - Sale
Common Stock
2022-07-05$60.00/sh−5,250$315,000→ 14,761 total - Exercise/Conversion
Common Stock
2021-08-05$21.04/sh+10,000$210,400→ 17,594 total - Sale
Common Stock
2022-04-01$62.71/sh−1,750$109,743→ 20,011 total - Exercise/Conversion
Stock Options (Right to buy)
2021-08-05−4,167→ 0 totalExercise: $34.10Exp: 2029-08-22→ Common Stock (4,167 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2021-08-05−10,000→ 0 totalExercise: $21.04Exp: 2029-04-08→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The shares subject to the option will vest in full on August 22, 2020.
- [F3]The shares subject to the option will vest in full on April 8, 2020.